Samuel Maclean, who has lived with the lung condition for several years, is among the first to benefit ...

With a target date for FDA approval less than a month away, Sanofi and Regeneron’s megablockbuster Dupixent has gained much attention as it is on the verge of becoming the first biologic to treat ...

Add Yahoo as a preferred source to see more of our stories on Google. Jul. 1—MORGANTOWN — A new treatment for emphysema is coming to West Virginia. The Zephyr Valve, a treatment classified a medical ...

The American Lung Association is announcing a new initiative to help people living with chronic obstructive pulmonary disease ...

FLORENCE, Italy — Exacerbations remain one of the major unresolved challenges in the management of chronic obstructive pulmonary disease (COPD), despite the introduction of new therapies. However, ...

Sino Biopharmaceutical inks a licensing deal with AstraZeneca for a respiratory drug, with milestones and royalties worth ...

Add Yahoo as a preferred source to see more of our stories on Google. Woman's World has affiliate partnerships. We receive compensation when you click on a link and make a purchase. Learn more! Sure, ...

It seems patient satisfaction is low when it comes to their chronic obstructive pulmonary disease (COPD) treatment, according to a recent report out from consultancy Phreesia Life Sciences. When ...

Are you finding that your chronic obstructive pulmonary disease (COPD) is making it harder to do the things you enjoy? Canceling plans more often? Missing work due to flare-ups? It could mean your ...

Chronic obstructive pulmonary disease (COPD) is a group of respiratory conditions that include emphysema and chronic bronchitis. It can cause symptoms such as: shortness of breath frequent respiratory ...

To most people, cigarettes are often associated with lung cancer. However, smoking also causes other severe respiratory problems, such as COPD (chronic obstructive pulmonary disease). COPD occurs as a ...

This article supports the use of the chronic obstructive pulmonary disease (COPD) treatment ratio as a surrogate marker of COPD exacerbation risk for quality measurement purposes. Objectives: Despite ...